期刊文献+

连续性肾脏替代治疗行枸橼酸体外抗凝补碱策略对比研究 被引量:1

Two different alkali supplement strategies in continuous renal replacement therapy (CRRT) with citrateanticoagulation
下载PDF
导出
摘要 目的比较两种不同补碱策略在连续性肾脏替代治疗(CRRT)行枸橼酸抗凝中的效果。方法选取2013年5月至2015年4月于本院接受CRRT的患者63例,采用连续静脉一静脉血液滤过(CVVH)模式进行CRRT,采用枸橼酸抗凝行CRRT,随机分为两组,均行后稀释法,对照组根据置换液量计算补碱量;治疗组根据每小时枸橼酸进入人体量,推算生成碳酸氢根量,校正补碱量。比较两种补碱策略的人体酸碱平衡、CRRT的滤器寿命、钙值、跨膜压(TMP)、病死率。结果两组滤器寿命、滤器后离子钙值、TMP及病死率无明显差异(P〉0.05);但在CVVH4h后,对照组体内HCO,一均较治疗组升高,12h后对照组pH升高明显,差异均有统计学意义(P〈0.05),对照组在CVVH4~6h后均需调整补碱速度,直至体内酸碱平衡相对稳定。结论患者行CRRT枸橼酸抗凝时,根据枸橼酸入量校正补碱量,简单、安全、有效,可减少酸碱失衡的发生,进而减少监测血气分析频率。 Objective To compare two different alkali supplement strategies in contilmous renal replacement therapy (CRRT) with citrate anticoagulation. Methods 63 patients undertaking CRRT at our hospital from May, 2013 to April 2015 were selected. CRRT was carried out using continuous veno-venous hemofiltration (CVVH) mode and citrate anticoagulation. The patients were randomly divided into a control group and a treatment group. Post dilution method was used in both groups. The amount of alkali supplement was calculated in term of the volume of replacement fluid in the control group; the alk. i amount was corrected according the amount of HCO3 generated by the citrate dripped into the patientsodies one hour in the treatment group. The acid-base balance, CRRT filter's life time, calcium value, transmembrane pressure (TMP and mortality were compared between these two groups. Results There wer no statistical differences in life time, calcium value, TMP, and mortaqty bween these two groups (P〉 0.05). 4 hours after CVVH, the ,evel of HCO3 was higher in the control grou than in the treatment group; 12 hours after CVVH, pH was higher in the cool group than in the treatment grog; with statistical differences (P〈0.05). 4-6 hours after CVVH, the speed of al di supplement had to be adjusted oatil the acid-base balance was relatively stable. Conclusions When patients 'e undertaking CRRT under citrate ..nticoagulation, alkali amount should be adjust according to citrate amount. 1 's simple, safe, and effective and can reduce the occurrence of acid-base imbalance and the frequency of monitor ng blood gas analysis.
出处 《国际医药卫生导报》 2016年第12期1708-1710,共3页 International Medicine and Health Guidance News
关键词 肾脏替代治疗 枸橼酸 药物代谢动力学 Continuous renal replacement therapy Citrate Pharmacokinetics
  • 相关文献

参考文献13

  • 1黄桔秀,朱慧民,金礼通.连续性肾脏替代疗法治疗感染性休克的效果观察[J].中国急救复苏与灾害医学杂志,2012,7(4):321-325. 被引量:6
  • 2李莉,黄洁平,李荣藻.床旁单泵静-静脉血液滤过救治ICU多器官功能障碍综合征[J].国际医药卫生导报,2006,12(8):43-44. 被引量:3
  • 3郑寅,许钟烨,焦正,朱秋毓,刘骏峰,顾勇,林善锬,郝传明,丁峰.连续性肾脏替代治疗时枸橼酸药物代谢动力学数学模型的构建[J].中华肾脏病杂志,2010,26(6):432-437. 被引量:14
  • 4Kidney Disease Improving GlObal Outcomes Kidney.KDIGO Clinical Practice Guideline for Acute Kidney Injury[J]. Kidney Int, 2012, 2(Suppl): 1-138.
  • 5Ronco C, Bellomo R, Homel P, et al.Effect of different doses in continuous veno-venous haemofihration on outcome of acute renal failure: a prospective randomized trial[J].Lancet, 2000, 356(9223):26-30.
  • 6Hetzel GR, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofihration: a prospective randomized multicentre triM[J] Nephrol Dial Transplant, 2011, 26(1):232-239.
  • 7Nurmohamed SA, Vervloet MG, Girbes AR, et al.Continuous venovenous hemofihration with or without predilution regional citrate anticoagulation: a prospective study[J]. Blood Purif, 2007, 25(4):316-323.
  • 8Shum HP, Chan KC, Yan WW.R Regional citrate anticoagulation in predilution continuous venovenous hemofihration using prismocitrate 10/2 solution[J].Ther Apher Dial, 2012, 16(1):81-86.
  • 9Tolwani AJ, Campbell RC, Schenk MB, et al.Simplified citrate anticoagulation for continuous renal replacement therapy[J]. Kidney Int, 2001, 60(1):370-374.
  • 10Morgera S, Scholle C, Voss G, et al.Metabolic complications during regional citrate auticoagulation in continuous venovenous hemodialysis: single- center experience[J]. Nephron Clin Pract, 2004,97(4):c 131 - 136.

二级参考文献29

  • 1季大玺,龚德华.连续性血液净化在非肾脏病患者中的应用[J].肾脏病与透析肾移植杂志,2004,13(5):453-454. 被引量:67
  • 2姜虹,陈江华.连续性血液净化治疗多器官功能障碍综合征新进展[J].国外医学(移植与血液净化分册),2005,3(1):13-16. 被引量:11
  • 3Kutsogiannis DJ,Mayers I,Chin WD,et al.Regional citrate anticoagulation in continuous venovenous hemodiafiltration.Am J Kidney Dis,2002,35:802-811.
  • 4Tolwani AJ,Prendergast MB,Speer RR,et al.A practical citrate Anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.Clin J Am Soc Nephrol,2006,1:79-87.
  • 5Bunker JP,Bendixen HH,Murphy AJ.Hemodynamic effects of intravenously administered sodium citrate.N Engl J Med,1962,266:372-377.
  • 6Kutsogiannis DJ,Gibney RT,Stollery D,et al.Regional citrate versus systemic heparin anticongulation for continuous renal replacement in critically ill patients.Kidney Int,2005,67:2361-2367.
  • 7Hofbauer R,Moser D,Frass M,et al.Effect of anticoagulation on blood membrane interactions during hemodialysis.Kidney Int,1999,56:1578-1583.
  • 8Bagshaw SM,Laupland KB,Boiteau PJ,et al.Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.Crit Care,2005,20:155-161.
  • 9Dhondt A,Vanholder R,Tielemans C,et al.Effect of regional citrate anti-coagulation on leucopenia,complement activation,and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes.Nephron,2000,85:334-342.
  • 10Bohder J,Sehollmeyer P,Dressel B,et al.Reduction of granulocyte activation during hemodialysis with regional citrate antieoagulation:dissociation of complement activation and neutropenia from neutrophil degranulation.J Am Soc Nephrol,1996,7:234-241.

共引文献20

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部